| Entry |
|
|---|
| Name |
Benserazide (USAN/INN) |
|---|
| Formula |
C10H15N3O5
|
|---|
| Exact mass |
257.1012
|
|---|
| Mol weight |
257.24
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Cardiovascular agent
DG01617 Catecholamine synthesis inhibitors
|
|---|
| Remark |
|
|---|
| Efficacy |
Antiparkinsonian, Decarboxylase inhibitor |
|---|
| Comment |
Peripheral aromatic L-amino acid decarboxylase inhibitors (DCI)
|
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Structure map |
|
|---|
| Brite |
Drug groups [BR:br08330]
Cardiovascular agent
DG01617 Catecholamine synthesis inhibitors
DG01296 Benserazide
D03082 Benserazide
Target-based classification of drugs [BR:br08310]
Enzymes
Lyases (EC4)
Carboxy-lyases
DDC
D03082 Benserazide (USAN/INN)
Drug groups [BR:br08330]
Cardiovascular agent
DG01617 Catecholamine synthesis inhibitors
DG01296 Benserazide
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 18
1 C8y C 20.1225 -25.1372
2 C8y C 20.1225 -26.5395
3 C8x C 21.3399 -27.2406
4 C8x C 22.5501 -26.5395
5 C8y C 22.5501 -25.1372
6 C8y C 21.3399 -24.4361
7 O1a O 21.3416 -23.0337
8 O1a O 18.9084 -24.4354
9 O1a O 18.9084 -27.2413
10 C1b C 23.7557 -24.4432
11 N1b N 24.9668 -25.1443
12 N1b N 26.1778 -24.4502
13 C5a C 27.3889 -25.1513
14 C1c C 28.6000 -24.4573
15 C1b C 29.8110 -25.1585
16 O1a O 31.0221 -24.4645
17 O5a O 27.3859 -26.5536
18 N1a N 28.6030 -23.0549
BOND 18
1 2 9 1
2 2 3 1
3 5 10 1
4 3 4 2
5 10 11 1
6 4 5 1
7 11 12 1
8 5 6 2
9 12 13 1
10 6 1 1
11 13 14 1
12 14 15 1
13 6 7 1
14 15 16 1
15 13 17 2
16 1 8 1
17 14 18 1
18 1 2 2
|
|---|
